162 related articles for article (PubMed ID: 23258918)
1. Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
Straznicky NE; Lambert EA; Lambert GW
Diabetes; 2013 Jan; 62(1):e2. PubMed ID: 23258918
[No Abstract] [Full Text] [Related]
2. Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
Frontoni S
Diabetes; 2013 Jan; 62(1):e1. PubMed ID: 23258917
[No Abstract] [Full Text] [Related]
3. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
Rizvi AA; Stoian AP; Rizzo M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576200
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid transfer protein in diabetes, metabolic syndrome and obesity.
Qin S; Song G; Yu Y
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):149-53. PubMed ID: 25107452
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and the endothelium.
Quiñones MJ; Nicholas SB; Lyon CJ
Curr Diab Rep; 2005 Aug; 5(4):246-53. PubMed ID: 16033673
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension.
Yang M; Yang G; Dong J; Liu Y; Zong H; Liu H; Boden G; Li L
J Investig Med; 2010 Oct; 58(7):883-6. PubMed ID: 20601896
[TBL] [Abstract][Full Text] [Related]
9. The role of androgens in metabolism, obesity, and diabetes in males and females.
Navarro G; Allard C; Xu W; Mauvais-Jarvis F
Obesity (Silver Spring); 2015 Apr; 23(4):713-9. PubMed ID: 25755205
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].
Tobisch B; Blatniczky L; Barkai L
Orv Hetil; 2011 Jul; 152(27):1068-74. PubMed ID: 21676673
[TBL] [Abstract][Full Text] [Related]
11. Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes.
Fealy CE; Nieuwoudt S; Foucher JA; Scelsi AR; Malin SK; Pagadala M; Cruz LA; Li M; Rocco M; Burguera B; Kirwan JP
Exp Physiol; 2018 Jul; 103(7):985-994. PubMed ID: 29766601
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of the metabolic syndrome: insights from monogenic disorders.
Murphy R; Carroll RW; Krebs JD
Mediators Inflamm; 2013; 2013():920214. PubMed ID: 23766565
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.
Rao PM; Kelly DM; Jones TH
Nat Rev Endocrinol; 2013 Aug; 9(8):479-93. PubMed ID: 23797822
[TBL] [Abstract][Full Text] [Related]
14. Insulin action and resistance in obesity and type 2 diabetes.
Czech MP
Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and metabolic disorders.
Hotamisligil GS
Nature; 2006 Dec; 444(7121):860-7. PubMed ID: 17167474
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort.
Bo S; Musso G; Gambino R; Villois P; Gentile L; Durazzo M; Cavallo-Perin P; Cassader M
Am J Clin Nutr; 2012 Nov; 96(5):962-9. PubMed ID: 23034958
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
18. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
19. A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways.
Aronis KN; Mantzoros CS
Metabolism; 2012 Apr; 61(4):445-9. PubMed ID: 22304840
[No Abstract] [Full Text] [Related]
20. Are There Differences in Hair Mineral Concentrations Between Metabolically Healthy and Unhealthy Obese Adults?
Lee YA; Kim SH; Kim HN; Song SW
Biol Trace Elem Res; 2020 Feb; 193(2):311-318. PubMed ID: 30972534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
